Refresher Course: Head and Neck

RC 1908 - Updates on head and neck cancer imaging

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Pim De Graaf, Amsterdam / NL

2
Sinonasal tumours: what you need to know

Sinonasal tumours: what you need to know

15:00Suresh Mukherji, Ann Arbor / US

3
Imaging of extranodal tumour extension: why and how should it be done?

Imaging of extranodal tumour extension: why and how should it be done?

15:00Roberto Maroldi, Concesio / IT

4
HPV status and staging in oropharyngeal carcinoma

HPV status and staging in oropharyngeal carcinoma

15:00Suresh Mukherji, Ann Arbor / US

5
Panel discussion: Imaging in head and neck cancer: navigating the latest advances

Panel discussion: Imaging in head and neck cancer: navigating the latest advances

10:00Panel discussion: Imaging in head and neck cancer: navigating the latest advances

5 min
Chairperson's introduction
Pim De Graaf, Amsterdam / Netherlands
15 min
Sinonasal tumours: what you need to know
Suresh Mukherji, Ann Arbor / United States
  1. To review common tumours of the sinonasal cavity.
  2. To discuss imaging findings that are characteristic of certain tumours.
  3. To provide a checklist of "key elements" that should be included in the radiologist's report that specifically affect treatment.
15 min
Imaging of extranodal tumour extension: why and how should it be done?
Roberto Maroldi, Concesio / Italy
  1. To understand the clinical significance of extranodal extension (ENE) in head and neck cancers and its impact on prognosis and treatment planning.
  2. To learn the imaging features on CT and MRI that indicate the presence of extranodal extension in lymph nodes.
  3. To develop a systematic approach to accurately identify and report ENE to support optimal staging and therapeutic decision-making.
15 min
HPV status and staging in oropharyngeal carcinoma
Suresh Mukherji, Ann Arbor / United States
  1. To understand the role of HPV status, particularly p16 immunohistochemistry, in the diagnosis and classification of oropharyngeal squamous cell carcinoma.
  2. To learn the differences between HPV-positive and HPV-negative oropharyngeal cancer staging according to the latest AJCC TNM 9th edition system and their prognostic implications.
  3. To apply knowledge of HPV-related staging to guide clinical management and predict patient outcomes more accurately.
10 min
Panel discussion: Imaging in head and neck cancer: navigating the latest advances

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.